Filtered By:
Condition: Diabetes
Drug: Aspirin

This page shows you your search results in order of date. This is page number 6.

Order by Relevance | Date

Total 378 results found since Jan 2013.

Posterior Circulation Ischaemic Stroke
Am J Med Sci. 2022 Jan 29:S0002-9629(22)00030-1. doi: 10.1016/j.amjms.2021.10.027. Online ahead of print.ABSTRACTPosterior circulation ischaemic stroke (PCIS) is a disease of high burden. They account for 20-25% of all ischaemic strokes. However, it is relatively under-researched and requires more clinical attention, since it carries worse functional outcomes. Vertigo, visual disturbances and sensory/motor disturbances are found in PCIS. Large artery atherosclerosis and embolism are main causes of PCIS, while there is growing evidence that vertebrobasilar dolichoectasia is a key association. Hypertension is the commonest r...
Source: The American Journal of the Medical Sciences - February 1, 2022 Category: General Medicine Authors: Mr Alexander Ng Source Type: research

Low ‑dose Aspirin for Primary Prevention of Cardiovascular Events in Postmenopausal Women with Type‑2 Diabetes: The Prescriptive Approach in the Real World
Conclusions: Low ‑dose aspirin in our population is prescribed preferentially in postmenopausal women with type‑2 diabetes when affected by metabolic syndrome or metabolic cardiomyopathy, at the opposite women with only high risk have lower chance to receive aspirin.
Source: International Journal of Preventive Medicine - January 2, 2022 Category: International Medicine & Public Health Source Type: research

Prevalence of VOYAGER PAD trial exclusion criteria in unselected patients undergoing lower limb revascularisation
CONCLUSIONS: In unselected patients undergoing revascularisation for peripheral arterial disease, the majority presents with characteristics that, at present, preclude prescription of rivaroxaban in addition to aspirin. This patient cohort represents a population with higher rates of comorbidities and more complex vascular interventions, but might also benefit from dual pathway inhibition strategy.PMID:34913631 | DOI:10.23736/S0392-9590.21.04816-1
Source: International Angiology - December 16, 2021 Category: Cardiology Authors: Maria A Moll Daniela Zwerger Kristina J Grassl Werner Westreicher Sabrina B Neururer Clemens Wi Moll Sabine H Wipper Josef Klocker Source Type: research